샘플 요청 목록

 카트 문의
시장보고서
상품코드
1765141

세계의 오소바이오로직스 시장

Orthobiologics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 193 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

오소바이오로직스 세계 시장은 2030년까지 90억 달러에 이를 전망

2024년에 71억 달러로 추정되는 오소바이오로직스 세계 시장은 2024-2030년 CAGR 4.2%로 성장하여 2030년에는 90억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 관절내 보충 요법은 CAGR 5.1%를 나타내고, 분석 기간 종료시에는 41억 달러에 이를 것으로 예측됩니다. 합성 오소바이오로직스 분야의 성장률은 분석 기간중 CAGR 3.4%로 추정됩니다.

미국 시장은 19억 달러로 추정, 중국은 CAGR 3.8%로 성장 예측

미국의 오소바이오로직스 시장은 2024년에 19억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 14억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 3.8%로 추정됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.9%와 3.5%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.1%를 보일 전망입니다.

세계의 오소바이오로직스 시장 - 주요 동향과 촉진요인 정리

오소바이오로직스란 무엇이며, 왜 정형외과 의료에서 중요한가?

정형외과 시술에서 뼈, 근육, 힘줄, 인대의 치유를 촉진하기 위해 사용되는 생물학적 유래 물질입니다. 이러한 물질에는 다혈소판 혈장(PRP), 뼈 이식편, 줄기세포, 히알루론산 등이 포함되며, 염증을 억제하고 조직 재생을 촉진하며 회복을 가속화하여 신체의 자연 치유 과정을 개선하도록 설계되었습니다. 오소바이오로직스는 스포츠 외상, 퇴행성 관절 질환, 척추 질환의 치료에 널리 사용되고 있으며, 환자에게 수술에 대한 최소 침습적 대안을 제공하거나 경우에 따라서는 보조 요법으로 사용되어 수술 결과를 개선하는 데 도움이 됩니다. 신체의 자연적 재생 능력을 활용함으로써 근골격계 치료의 유망한 발전인 정위생물학은 더 빠른 치유를 가져오고 기존 치료와 관련된 합병증을 줄일 수 있습니다. 수술 이외의 치료법을 찾는 환자 증가와 정형외과 수술에서 생물학적 제제가 부상하고 있는 것이 그 채택이 확대되고 있는 배경입니다.

기술의 발전은 어떻게 오르소바이오로직스 산업을 형성하고 있는가?

기술 혁신은 특히 재생의료와 조직공학 분야에서 오르소바이오로직스 시장을 발전시키고 있습니다. 줄기세포 연구의 발전은 재생 치료의 가능성을 넓혔고, 줄기세포를 이용한 치료는 정형외과 환자의 연골, 뼈, 연부조직의 수복에 유망한 치료법으로 여겨지고 있습니다. 혈소판이 농축된 혈소판을 손상된 조직에 주입하여 치유를 촉진하는 혈소판이 풍부한 혈장(PRP) 요법의 개선도 다양한 근골격계 손상에 대한 비수술적 치료의 효과를 높이고 있습니다. 또한, 천연 뼈의 특성을 모방한 합성 뼈 이식의 개발로 정형외과 의사들은 척추 고정술 및 외상 환자에서 뼈 재생을 위한 선택의 폭이 넓어졌습니다. 또한, 비계 및 하이드로겔 사용과 같은 오소바이오로직스 전달 시스템의 혁신은 이러한 치료의 정확성과 효능을 향상시키고 있습니다. 이러한 기술적 진보로 인해 정형생체공학의 적용 범위가 넓어지고, 관절의 수복에서 척추의 변형에 이르기까지 보다 광범위한 증상에 적용될 수 있게 되었습니다.

오르소바이오로직스는 어디에서 가장 많이 사용되는가?

정형외과, 스포츠의학, 외상치료에 주로 사용되며, 척추 고정술, 관절 수복, 연부조직 재생에 대한 응용이 증가하고 있습니다. 스포츠 의학에서 PRP와 줄기세포 치료는 건염, 인대 파열, 연골 손상 등의 부상 치료에 널리 사용되어 운동선수의 조기 회복과 수술 회피에 도움을 주고 있습니다. 정형외과에서는 척추 고정술과 같이 뼈의 성장을 가속하고 척추를 안정화시키기 위해 뼈 이식이나 대체 뼈가 필요한 시술에 오르소바이오로직스가 자주 사용됩니다. 특히 무릎이나 어깨 관절 재건술은 조직 회복을 촉진하고 회복 시간을 단축하기 위해 정위생물학이 자주 사용되는 분야입니다. 또한, 오소바이오로직스는 골관절염과 같은 퇴행성 관절 질환의 치료에도 사용되어 통증 완화 및 관절 기능 회복에 도움을 주고 있습니다. 또한 외상 치료에도 사용이 확대되고 있으며, 특히 골유합 촉진이 필요한 복잡한 골절에 사용되고 있습니다.

오르소바이오로직스 시장 성장의 원동력은 무엇인가?

오소바이오로직스 시장의 성장은 근골격계 질환의 유병률 증가, 최소침습적 시술에 대한 수요 증가, 재생의료의 발전 등 여러 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 세계 인구의 고령화이며, 이로 인해 골관절염, 골다공증과 같은 정형외과 질환의 유병률이 높아지고 있으며, 모두 정형외과적 생물학적 치료가 효과적입니다. 저침습적이고 비수술적인 치료법에 대한 수요가 증가하고 있는 것도 중요한 촉진요인입니다. 줄기세포 치료, 다혈소판 혈장(PRP), 뼈 이식 대체물 등의 기술 발전으로 인해 오소바이오로직스으로 치료할 수 있는 질환의 범위가 더욱 넓어지고, 더 효과적이고 쉽게 이용할 수 있게 되었습니다. 또한, 최첨단 치료를 원하는 프로 운동선수와 활동적인 사람들이 스포츠 의학에서 정위생물학을 점점 더 많이 채택하고 있는 것도 시장 성장에 기여하고 있습니다. 마지막으로, 정형외과 의료에서 생물학적 제제의 이점에 대한 인식이 높아지고 이 분야의 지속적인 연구 개발은 임상 및 수술 장면 모두에서 이러한 치료법의 광범위한 사용을 촉진하고 있습니다.

부문

제품(관절내 보충 요법, 합성 오소바이오로직스, DBM, BMP, 기타 제품);용도(골관절염 및 퇴행성 관절염, 골절 회복, 척추 고정, 연부 조직 손상, 기타 용도)

조사 대상 기업 예

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

LSH 25.07.15

Global Orthobiologics Market to Reach US$9.0 Billion by 2030

The global market for Orthobiologics estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Synthetic Orthobiologics segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 3.8% CAGR

The Orthobiologics market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Orthobiologics Market - Key Trends & Drivers Summarized

What Are Orthobiologics, and Why Are They Critical in Orthopedic Medicine?

Orthobiologics are biologically derived substances used to enhance the healing of bones, muscles, tendons, and ligaments in orthopedic procedures. These substances, which include platelet-rich plasma (PRP), bone grafts, stem cells, and hyaluronic acid, are designed to improve the body’s natural healing processes by reducing inflammation, promoting tissue regeneration, and accelerating recovery. Orthobiologics are widely used in treatments for sports injuries, degenerative joint diseases, and spinal conditions, offering patients a minimally invasive option to surgery or, in some cases, improving surgical outcomes when used as an adjunct therapy. By leveraging the body’s natural regenerative capacity, orthobiologics represent a promising advancement in musculoskeletal care, providing faster healing and reducing complications associated with traditional treatments. Their growing adoption is being driven by increased patient demand for non-surgical treatment options and the rise of biologics in orthopedic surgery.

How Are Technological Advancements Shaping the Orthobiologics Industry?

Technological innovations are propelling the orthobiologics market forward, particularly in the areas of regenerative medicine and tissue engineering. Advances in stem cell research have expanded the possibilities for regenerative treatments, with stem cell-based therapies showing promise in repairing cartilage, bone, and soft tissues in orthopedic patients. The refinement of platelet-rich plasma (PRP) therapies, where concentrated platelets are injected into damaged tissue to promote healing, has also increased the effectiveness of non-surgical treatments for a variety of musculoskeletal injuries. Furthermore, developments in synthetic bone graft substitutes, which mimic the properties of natural bone, are offering orthopedic surgeons more options for bone regeneration in spinal fusion and trauma cases. Additionally, innovations in the delivery systems for orthobiologics, such as the use of scaffolds or hydrogels, are improving the precision and efficacy of these therapies. These technological advancements are enhancing the scope of orthobiologics, making them more versatile and applicable to a wider range of conditions, from joint repair to spinal deformities.

Where Are Orthobiologics Being Used Most Extensively?

Orthobiologics are primarily used in orthopedic surgeries, sports medicine, and trauma care, with increasing applications in spinal fusion, joint repair, and soft tissue regeneration. In sports medicine, PRP and stem cell therapies are widely used to treat injuries such as tendonitis, ligament tears, and cartilage damage, helping athletes recover faster and avoid surgery. In orthopedic surgery, orthobiologics are frequently used in procedures like spinal fusion, where bone grafts or bone substitutes are needed to promote bone growth and stabilize the spine. Joint reconstruction, particularly in the knee and shoulder, is another area where orthobiologics are commonly employed to enhance tissue repair and reduce recovery times. Moreover, orthobiologics are gaining traction in treating degenerative joint diseases such as osteoarthritis, where they help alleviate pain and restore joint function. Their use in trauma care is also expanding, particularly for complex fractures that require enhanced bone healing.

What Is Driving the Growth of the Orthobiologics Market?

The growth in the orthobiologics market is driven by several factors, including the rising prevalence of musculoskeletal disorders, an increasing demand for minimally invasive procedures, and advancements in regenerative medicine. One of the primary drivers is the aging global population, which is leading to a higher incidence of orthopedic conditions such as osteoarthritis and osteoporosis, both of which benefit from orthobiologic treatments. The growing demand for minimally invasive and non-surgical treatment options is another significant driver, as patients increasingly seek alternatives to traditional surgery for faster recovery and fewer complications. Technological advancements in stem cell therapies, platelet-rich plasma (PRP), and bone graft substitutes are further expanding the range of conditions that can be treated with orthobiologics, making them more effective and accessible. Additionally, the increasing adoption of orthobiologics in sports medicine, driven by professional athletes and active individuals looking for cutting-edge treatments, is contributing to market growth. Lastly, the rising awareness of the benefits of biologics in orthopedic care, coupled with ongoing research and development in the field, is driving the broader use of these therapies in both clinical and surgical settings.

SCOPE OF STUDY:

The report analyzes the Orthobiologics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, Other Products); Application (Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Arthrex, Inc.
  • Bioventus LLC
  • DePuy Synthes
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Kuros Biosciences AG
  • Medtronic PLC
  • NuVasive, Inc.
  • Orthofix International NV
  • RTI Surgical, Inc.
  • SeaSpine Holdings Corporation
  • Stryker Corporation
  • XTANT Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Orthobiologics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Musculoskeletal Disorders Spurs Growth in the Orthobiologics Market
    • Growing Demand for Minimally Invasive Surgical Techniques Strengthens Business Case for Orthobiologics
    • Increasing Focus on Regenerative Medicine Drives Adoption of Orthobiologics in Joint Repair and Replacement
    • Advancements in Stem Cell and Growth Factor Therapies Propel Innovation in Orthobiologics
    • Surge in Aging Population and Increasing Incidence of Osteoarthritis Expands Addressable Market for Orthobiologics
    • Growing Focus on Biocompatibility and Bioabsorbable Materials Fuels Innovation in Orthobiologic Products
    • Rising Use of Orthobiologics in Sports Medicine Fuels Growth in Cartilage Repair and Tissue Regeneration
    • Growing Application of Orthobiologics in Fracture Healing Expands Opportunities in Trauma Care
    • Increasing Focus on Personalized Orthopedic Treatments Drives Demand for Orthobiologics in Customized Therapies
    • Expansion of Orthobiologics in Non-Surgical Treatments for Chronic Pain and Joint Degeneration Propels Market Growth
    • Advances in 3D Printing and Biologics-Based Implants Strengthen Market for Orthobiologics in Complex Surgeries
    • Increasing Use of Platelet-Rich Plasma (PRP) in Orthopedic Therapies Expands the Orthobiologics Market
    • Rising Demand for Orthobiologics in Spinal Fusion Procedures Boosts Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Orthobiologics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Viscosupplementation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Viscosupplementation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Orthobiologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Synthetic Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for DBM by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for DBM by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for BMP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for BMP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Osteoarthritis & Degenerative Arthritis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Osteoarthritis & Degenerative Arthritis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fracture Recovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Fracture Recovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Soft Tissue Injuries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Soft Tissue Injuries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Orthobiologics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Orthobiologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Orthobiologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Orthobiologics by Product - Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Orthobiologics by Product - Percentage Breakdown of Value Sales for Viscosupplementation, Synthetic Orthobiologics, DBM, BMP and Other Products for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Orthobiologics by Application - Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Orthobiologics by Application - Percentage Breakdown of Value Sales for Osteoarthritis & Degenerative Arthritis, Fracture Recovery, Spinal Fusion, Soft Tissue Injuries and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제